FACULTY
Prevention of Cardiovascular Disease with Aspirin Therapy: Is it for Everyone?
Activity Date: August 2003  — Activity Info: Volume 3, (8B)
Goals & Objectives | Faculty | Introduction | Full Activity Content | CME Test & Evaluation (CME Expired) | Order Copy of Activity

 

Full Disclosure Policy Affecting CME Activities:
As sponsors accredited by the Accreditation Council for Continuing Medical Education (ACCME) and the American Council on Pharmaceutical Education (ACPE), it is the policy of Johns Hopkins University School of Medicine and the University of Tennessee College of Pharmacy to require the disclosure of the existence of any significant financial interest or any other relationship a faculty member or a sponsor has with the manufacturer(s) of any commercial product(s) discussed in an educational presentation. The Program Director and Participating Faculty reported the following:

PROGRAM DIRECTOR

    Roger S. Blumenthal, MD, FACC, FCCP
    Associate Professor of Medicine
    Director, Preventive Cardiology
    Johns Hopkins Ciccarone Center for the Prevention of Heart Disease
    Johns Hopkins University School of Medicine
    Baltimore, Maryland
    • Dr Blumenthal reports receiving grant and/or research support and honoraria from Merck & Co, Inc, Novartis Corporation, Pfizer, Inc, and Wyeth.

PARTICIPATING FACULTY

    Michael Miller, MD, FACC, FAHA
    Associate Professor of Medicine and Epidemiology
    Director, Center for Preventive Cardiology
    Division of Cardiology
    University of Maryland Medical Center
    Baltimore, Maryland
    • Dr Miller reports having no financial or advisory relationships with corporate organizations related to this activity.

    Emile R. Mohler III, MD
    Director, Vascular Medicine
    University of Pennsylvania Health System
    Philadelphia, Pennsylvania
    • Dr Mohler reports having no financial or advisory relationships with corporate organizations related to this activity.

    Eric J. Topol, MD
    Chairman, Department of Cardiovascular Medicine
    Department of Cardiology
    Cleveland Clinic Foundation
    Cleveland, Ohio
    • Dr Topol reports receiving grant and/or research support from Bristol-Myers Squibb Company and Sanofi Synthelabo Inc.

Notice:
In accordance with the ACCME Standards for Commercial Support, the audience is advised that one or more articles in this continuing medical education activity may contain reference(s) to unlabeled or unapproved uses of drugs or devices.

Faculty have indicated that they have not referenced unlabeled/unapproved uses of drugs or products.

Advanced Studies in Medicine provides disclosure information from contributing authors, lead presenters, and participating faculty. Advanced Studies in Medicine does not provide disclosure information from authors of abstracts and poster presentations. The reader shall be advised that these contributors may or may not maintain financial relationships with pharmaceutical companies.

     
Home | Contact Us | View Account | Need Help?